
about 11 years ago // #HealthyMeans new ideas
What are the vital components of biopharmaceutical innovation and the conditions needed to create value in the form of new medicines for patients wherever they live in the world? Eli Lilly & Co. CEO and IFPMA President John Lechleiter shares his thoughts in an exclusive conversation for #HealthyMeans.